Author Kleiter, Ingo
-
2008 | Conference Abstract
The TGF-beta inhibitor Smad7 controls t cell differentiation and susceptibility to autoimmune encephalomyelitis
Kleiter, I.; Song, J.; Croxford, A.; Lukas, D.; Fantini, M. C.; Pedre, X. & Hasan, M. et al. (2008)
MULTIPLE SCLEROSIS, 14 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, CANADA.
London: Sage Publications Ltd.
Details WoS
-
2012 | Journal Article |
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Jarius, S.; Ruprecht, K.; Wildemann, B.; Kuempfel, T.; Ringelstein, M.; Geis, C. & Kleiter, I. et al. (2012)
Journal of Neuroinflammation, 9 art. 14. DOI: https://doi.org/10.1186/1742-2094-9-14
Details DOI PMID PMC WoS
-
2015 | Review |
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J. L.; de Seze, J.; Lana-Peixoto, M. A.; Palace, J.; Waldman, A.; Schippling, S.& Tenembaum, S. N. et al. (2015)
Multiple Sclerosis Journal, 21(6) pp. 678-688.
Sage Publications Ltd. DOI: https://doi.org/10.1177/1352458514567216
Details DOI PMID PMC WoS
-
2016 | Conference Abstract
Efficacy of immunotherapies and predictors of therapy response in neuromyelitis optica spectrum disorders: analysis of 397 treatment years from 150 patients
Stellmann, J.-P.; Krumbholz, M.; Friede, T.; Trebst, C. & Kleiter, I. (2016)
Multiple Sclerosis Journal, 22 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND.
London: Sage Publications Ltd.
Details WoS
-
2017 | Journal Article
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Stellmann, J.-P.; Krumbholz, M.; Friede, T. ; Gahlen, A.; Borisow, N.; Fischer, K. & Hellwig, K. et al. (2017)
Journal of Neurology, Neurosurgery & Psychiatry, 88(8) pp. 639-647. DOI: https://doi.org/10.1136/jnnp-2017-315603
Details DOI
-
2018 | Journal Article
Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions
Grüter, T.; Metz, I.; Gahlen, A.; Kneiphof, J.; Stork, L.; Brück, W. & Gold, R. et al. (2018)
Clinical and Experimental Neuroimmunology, 9(3) pp. 169-172. DOI: https://doi.org/10.1111/cen3.12466
Details DOI
-
2020 | Journal Article
The transitional phase of multiple sclerosis: Characterization and conceptual framework
Kleiter, I.; Ayzenberg, I.; Havla, J.; Lukas, C.; Penner, I.-K.; Stadelmann, C. & Linker, R. A (2020)
Multiple Sclerosis and Related Disorders, 44 pp. 102242. DOI: https://doi.org/10.1016/j.msard.2020.102242
Details DOI
-
2020 | Journal Article
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al. (2020)
Neurology, 94(4) pp. e407-e418. DOI: https://doi.org/10.1212/WNL.0000000000008684
Details DOI
-
2020 | Journal Article |
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al. (2020)
Journal of Neuroinflammation, 17(1). DOI: https://doi.org/10.1186/s12974-020-01824-2
Details DOI
-
2020 | Journal Article
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
Abdelhak, A.; Huss, A.; Stahmann, A.; Senel, M.; Krumbholz, M.; Kowarik, M. C. & Havla, J. et al. (2020)
Contemporary Clinical Trials Communications, 18 pp. 100574. DOI: https://doi.org/10.1016/j.conctc.2020.100574
Details DOI
-
2021 | Journal Article
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder
Ayzenberg, I.; Richter, D.; Henke, E.; Asseyer, S.; Paul, F.; Trebst, C. & Hümmert, M. W. et al. (2021)
Neurology: Neuroimmunology & Neuroinflammation, 8(3) pp. e985. DOI: https://doi.org/10.1212/NXI.0000000000000985
Details DOI
-
2023 | Journal Article
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
Abdelhak, A.; Antweiler, K.; Kowarik, M. C.; Senel, M.; Havla, J.; Zettl, U. K. & Kleiter, I. et al. (2023)
Annals of Clinical and Translational Neurology, art. acn3.51969. DOI: https://doi.org/10.1002/acn3.51969
Details DOI
-
2024 | Journal Article
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis
Abdelhak, A.; Antweiler, K.; Kowarik, M. C.; Senel, M.; Havla, J.; Zettl, U. K. & Kleiter, I. et al. (2024)
Multiple Sclerosis and Related Disorders, 81 art. 105139. DOI: https://doi.org/10.1016/j.msard.2023.105139
Details DOI